Stocks Listing
EXAS

Exact Sciences Corporation

Share
EXAS
$42.65 1.02%Last Updated Nov 25 2022 08:56 PM
1D Low / 1D High
Low:$42.14
High:$43.02
1D
1.02%
5D
0.28 %
30D
23.27 %
BulletPurple
Market Cap
$7,578,223,104
1.02 %
7.6 B
BulletBlue
Volume 1D
420,890
-
420.9 K
BulletOrange
Circulating Supply
177,684,012 EXAS
177.7 M

Price Chart

1D
5D
1M
6M
YTD
1Y
MAX
About

Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for breast, prostate, and colon cancers; Oncotype MAP, a tissue test delivering tumor profiling to aid therapy selection for patients with advanced, metastatic, refractory, or recurrent cancer; Oncotype DX AR-V7 Nucleus Detect Test, a liquid-based test for advanced stage prostate cancer; and Covid-19 testing services. The company's pipeline products focus on enhancing the Cologuard test's performance characteristics and developing blood and other fluid-based tests. It has license agreements with MAYO Foundation for Medical Education and Research; and Hologic, Inc. Exact Sciences Corporation was incorporated in 1995 and is headquartered in Madison, Wisconsin.

Historical data

1D
5D
1M
6M
1Y
MAX
Day
Open - Close
Low/High
Volume
Market Cap
Show More
Market Status
Opened
NCM
NASDAQ Stock Exchange
USA
Closes in
5 hours, 58 minutes
Working Hours
Mon-Fri, 02:30 PM - 09:00 PM
Timezone
GMT+0